Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]

Aydan Eroǧlu, A. Ulu, R. Çam, N. Akar

Research output: Contribution to journal › Article

3 Citations (Scopus)

Abstract

In summary, we found that PAI-1 4G/5G polymorphism is associated with the risk of malignant tumor development and we suggest that this polymorphism may contribute to an inherited predisposition to the development of malignancies; however further studies with larger series from diverse ethnic populations are needed to confirm our results.

Original languageEnglish (US)
Pages (from-to)135-136
Number of pages2
JournalJournal of B.U.ON.
Volume12
Issue number1
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Plasminogen Activator Inhibitor 1
Genes
Neoplasms
Population

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Eroǧlu, A., Ulu, A., Çam, R., & Akar, N. (2007). Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]. Journal of B.U.ON., 12(1), 135-136.

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]. / Eroǧlu, Aydan; Ulu, A.; Çam, R.; Akar, N.

In: Journal of B.U.ON., Vol. 12, No. 1, 01.2007, p. 135-136.

Research output: Contribution to journal › Article

Eroǧlu, A, Ulu, A, Çam, R & Akar, N 2007, 'Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]', Journal of B.U.ON., vol. 12, no. 1, pp. 135-136.
Eroǧlu A, Ulu A, Çam R, Akar N. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]. Journal of B.U.ON. 2007 Jan;12(1):135-136.
Eroǧlu, Aydan ; Ulu, A. ; Çam, R. ; Akar, N. / Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]. In: Journal of B.U.ON. 2007 ; Vol. 12, No. 1. pp. 135-136.
@article{bebd6b666b4d4d8c835c39005e44d245,
title = "Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]",
abstract = "In summary, we found that PAI-1 4G/5G polymorphism is associated with the risk of malignant tumor development and we suggest that this polymorphism may contribute to an inherited predisposition to the development of malignancies; however further studies with larger series from diverse ethnic populations are needed to confirm our results.",
author = "Aydan Eroǧlu and A. Ulu and R. {\cC}am and N. Akar",
year = "2007",
month = "1",
language = "English (US)",
volume = "12",
pages = "135--136",
journal = "Journal of B.U.ON.",
issn = "1107-0625",
publisher = "Balkan Union of Oncology",
number = "1",

}

TY - JOUR

T1 - Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]

AU - Eroǧlu, Aydan

AU - Ulu, A.

AU - Çam, R.

AU - Akar, N.

PY - 2007/1

Y1 - 2007/1

N2 - In summary, we found that PAI-1 4G/5G polymorphism is associated with the risk of malignant tumor development and we suggest that this polymorphism may contribute to an inherited predisposition to the development of malignancies; however further studies with larger series from diverse ethnic populations are needed to confirm our results.

AB - In summary, we found that PAI-1 4G/5G polymorphism is associated with the risk of malignant tumor development and we suggest that this polymorphism may contribute to an inherited predisposition to the development of malignancies; however further studies with larger series from diverse ethnic populations are needed to confirm our results.

UR - http://www.scopus.com/inward/record.url?scp=34249731935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249731935&partnerID=8YFLogxK

M3 - Article

C2 - 17436417

AN - SCOPUS:34249731935

VL - 12

SP - 135

EP - 136

JO - Journal of B.U.ON.

JF - Journal of B.U.ON.

SN - 1107-0625

IS - 1

ER -

Access to Document